Talk:C-Met inhibitor

This is the talk page for discussing improvements to the C-Met inhibitor article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about C-Met inhibitor.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

original name

Until April 2012 this article was Discovery and development of small molecule c-Met inhibitors

chlorine placed wrong in structure

There is small error in the structure of SU11274: chlorine should be in meta-position, not para in the phenyl ring. Stereochemistry in the chiral pyrrolidine ring of structure of PHA-665752 is not shown. — Preceding unsigned comment added by Tanevala (talk • contribs) 06:45, 5 October 2011 (UTC)[reply]

Any updates for 2012

Article doesn't seem to use any 2012 sources so the status of clinical trials may be out of date now. - Rod57 (talk) 00:22, 19 December 2012 (UTC)[reply]

tivantinib 'conflict'

Actually there is more detail here than in tivantinib so perhaps the detail should be moved there. - Rod57 (talk) 19:36, 20 February 2017 (UTC)[reply]